Nuala Moran

Leo Pharma A/S is further expanding its dermatology franchise with the $435 million acquisition of dersimelagon, potentially the first orally available treatment for rare photosensitivity diseases, from Tanabe Pharma Corp.

Snipr Biome ApS has published the first patient data for SNIPR-001, a CRISPR-modified bacteriophage to treat antibiotic-resistant Escherichia

Three months on, the emergency response to block transmission of the Bundibugyo Ebola virus in the Democratic Republic of Congo (DRC) is failing to stop its spread and at the current rate the outbreak will eclipse that in West Africa, 2014-2016, which is the deadliest to date. The fragility of the healthcare system in DRC, an active armed conflict and a highly mobile population are among the factors driving this.

There is progress to report on the U.K. government’s commitment to reduce the use of animals in research, with the formation of a new national center to validate and standardize patient-derived organoids.

New research has redefined how free-floating fibrinogen molecules self-assemble when they come into contact with air, overturning current understanding of how the blood clotting factor initiates the process of wound healing.

National drug regulators in Europe have ordered the recall of all batches of Amgen Inc.'s Tavneos (avacopan) after the European Commission formally canceled its marketing authorization for the vasculitis treatment earlier this month.

Researchers in the U.K. who previously showed GSK plc's Shingrix is associated with a lower risk of dementia have now extended their findings to link the recombinant shingles vaccine to a lower risk of cardiovascular disease.

New research has redefined how free-floating fibrinogen molecules self-assemble when they come into contact with air, overturning current understanding of how the blood clotting factor initiates the process of wound healing.

As yet, there are no approved microbiome-based products in the U.K., but the Medicines and Healthcare products Regulatory Agency (MHRA) has now asserted that they fall within the scope of existing regulations and published a position paper clarifying what evidence it will require in marketing applications.

Despite concerted efforts, transmission of the Bundibugyo virus in the Democratic Republic of Congo (DRC) is continuing to outpace control measures, and 100 days since the health emergency was declared is the fastest spreading outbreak on record. In the most recent official count on Aug. 26, the number of confirmed cases stood at 5,713, with 2,744 deaths. To date, the daily average of confirmed cases is markedly higher than in the first three months of the 2014 – 2016 Ebola outbreak in West Africa, or in the 2018 – 2020 outbreak in DRC.